Cord Blood Stem Cell TransplantationTransplantation, AutologousFetal BloodTransplantation, HomologousTransplantation ConditioningHematopoietic Stem Cell TransplantationGraft vs Host DiseaseHematologic NeoplasmsLiver TransplantationHistocompatibility TestingBone Marrow TransplantationGraft SurvivalTransplantation ChimeraKidney TransplantationTissue DonorsHistocompatibilityTransplantsBlood BanksTreatment OutcomeAllograftsMyeloablative AgonistsHLA AntigensHeart TransplantationStem Cell TransplantationLung TransplantationImmunogenetic PhenomenaLeukemiaGraft RejectionChimerismImmunosuppressive AgentsWhole-Body IrradiationPeripheral Blood Stem Cell TransplantationHematologic DiseasesRetrospective StudiesGraft vs Leukemia EffectUnrelated DonorsRecurrenceOrgan TransplantationBlood Transfusion, AutologousCytomegalovirus InfectionsVidarabineVolvariellaAntilymphocyte SerumCell TransplantationPancreas TransplantationTime FactorsSurvival AnalysisIslets of Langerhans TransplantationTransplantation ImmunologyTransplantationDisease-Free SurvivalAnemia, AplasticHematopoietic Stem CellsLeukodystrophy, Globoid CellBlood DonorsSurvival RateLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic SyndromesAcute DiseaseTransplantation, IsogeneicHematopoiesisColony-Forming Units AssayFollow-Up StudiesAntigens, CD34Living DonorsTransplantation, HeterotopicInfectionHeart-Lung TransplantationImmunophenotypingInfant, NewbornLeukocyte CountCytomegalovirusEpstein-Barr Virus InfectionsCombined Modality TherapyImmunosuppressionTransplantation ToleranceTissue and Organ ProcurementRisk FactorsSkin TransplantationLiver FailureFetal Tissue TransplantationPostoperative ComplicationsMesenchymal Stem Cell TransplantationKiller Cells, NaturalMelphalanTransplantation, HeterologousTissue TransplantationIncidenceNeutrophilsCyclophosphamideRemission InductionMultiple MyelomaWaiting ListsCorneal TransplantationBusulfanCyclosporineT-LymphocytesTacrolimusLymphoma, Non-Hodgkin